ReShape Lifesciences Inc.
NASDAQ:RSLS 3:59:44 PM EDT
| Market Cap (Intraday) | 7.27M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.35 |
| 50-Day MA | $0.44 |
| 200-Day MA | $0.95 |
ReShape Lifesciences Inc. Stock, NASDAQ:RSLS
1001 Calle Amanecer, San Clemente, California 92673
United States of America
Phone: +1.949.429.6680
Number of Employees: 47
Description
ReShape Lifesciences, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShapeCare and Diabetes Bloc-Stim Neuromodulation Device. The company was founded in December 2002 and is headquartered in San Clemente, CA.